Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Phase 1 / 2 Study to Evaluate SNDX- 6352 in Subjects With Active cGVHD

Multiple Cancer Types

This is a Phase 1 / 2, Open-label, Dose Escalation study to investigate SNDX-6352 in subjects with active cGVHD.
Hematologic, Phase I
I
Jagasia, Madan
NCT03604692
VICCBMTP18109

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: